---
document_datetime: 2023-09-21 19:08:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/protaphane-epar-all-authorised-presentations_en.pdf
document_name: protaphane-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.0741967
conversion_datetime: 2025-12-14 14:32:07.033258
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name    | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging                 | Content (concentration)   | Pack size                   |
|------------------|--------------------|------------|--------------------------|---------------------------|-------------------------------------|---------------------------|-----------------------------|
| EU/1/02/234/001  | Protaphane         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 1 vial                      |
| EU/1/02/234/002  | Protaphane         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 5 vials                     |
| EU/1/02/234/003  | Protaphane         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 1 vial                      |
| EU/1/02/234/004  | Protaphane         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 5 vials                     |
| EU/1/02/234/005  | Protaphane Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 1 cartridge                 |
| EU/1/02/234/006  | Protaphane Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 5 cartridges                |
| EU/1/02/234/007  | Protaphane Penfill | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass)                   | 3 ml (3.5 mg/ml)          | 10 cartridges               |
| EU/1/02/234/010  | Protaphane InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 1 pre-filled pen            |
| EU/1/02/234/011  | Protaphane InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 5 pre-filled pens           |
| EU/1/02/234/012  | Protaphane InnoLet | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 10 pre-filled pens          |
| EU/1/02/234/013  | Protaphane FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 1 pre-filled pen            |
| EU/1/02/234/014  | Protaphane FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 5 pre-filled pens           |
| EU/1/02/234/015  | Protaphane FlexPen | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Cartridge (glass) in pre-filled pen | 3 ml (3.5 mg/ml)          | 10 pre-filled pens          |
| EU/1/02/234/016  | Protaphane         | 40 iu/ml   | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (1.4 mg/ml)         | 5 (5 x 1) vials (multipack) |
| EU/1/02/234/017  | Protaphane         | 100 iu/ml  | Suspension for injection | Subcutaneous use          | Vial (glass)                        | 10 ml (3.5 mg/ml)         | 5 (5 x 1) vials (multipack) |